NMPS is presenting at this conference.
*****
Updated Company Presentation List: Companies Prepare For Cruttenden
Roth Healthcare Conference; Former FDA Commissioner Featured
PR Newswire - April 30, 1997 08:36
IRVINE, Calif., April 30 /PRNewswire/ -- Emerging growth companies in the biomed, medical devices and healthcare industries will be featured at the Annual Cruttenden Roth Healthcare Conference, scheduled May 19-20 at the St. Regis Hotel in New York City.
Featured speaker at this year's conference is former FDA Commissioner Dr. David A. Kessler, who will be addressing the 500-plus attendees at the Tuesday, May 20 luncheon. Until this past March, Dr. Kessler served as FDA Commissioner for seven years under both the Bush and Clinton Administrations. On July 1st he will become Dean of the Yale University School of Medicine.
The goal of the 72 public and ten private presenting companies will be to capture the interests of the nation's institutional investors and portfolio managers; the kind of interest that can infuse additional capital needed for continued research and development of new medical products and services.
Cruttenden Roth, a Western US-based underwriter specializing in emerging growth companies, sponsors this conference to provide "small cap healthcare companies an opportunity to meet one-on-one with some of the most influential investors and analysts on Wall Street," said Byron Roth, President of Cruttenden Roth.
During the two-day event, top management from each company will be
allocated a 20-minute segment to present their company stories. Presentations will be followed by breakout sessions for public companies where investors will get face time with each company's management, and receive hands-on demonstrations of the company's products and services.
Co-sponsors of this year's conference include Stradling Yocca Carlson & Rauth, a leading Western US law firm; Arthur Andersen, one of the world's largest accounting and auditing firms; PR Newswire, the international press relations service; and RR Donnelly, financial publishers.
Institutional investors, financial advisors, analysts and portfolio managers will be hosted. For registration information contact Cruttenden Roth's conference desk: (714) 757-5786.
Cruttenden Roth is a regional investment bank and brokerage specializing in emerging growth companies. One of the most active regional underwriters in the west, the firm has won recognition as one of the best performing underwriters in the nation, based on aftermarket performance. Headquartered in Irvine, California, the Company maintains regional offices in Los Angeles, Santa Barbara, Sam Francisco, Seattle and Denver. It is a member of the National Association of Securities Dealers (NASD), the Securities Industry
Association (SIA), and the Securities Investor Protection Corporation (SIPC).
Arrangements for the appearance of David Kessler made through Greater Talent Network Inc., New York, NY.
PARTIAL LIST OF PRESENTING COMPANIES:
Public Companies
AccuMed International, Inc. (ACMI) LifeCell Corporation (LIFC)
Aksys, Ltd. (AKSY) Matria Healthcare, Inc. (MATR)
Alkermes, Inc. (ALKS) Matritech, Inc. (NMPS)
Alliance Pharmaceutical Corp. (ALLP) Medical Asset Management, Inc.
(MAMT)
Anika Therapeutics, Inc. (ANIK) Medstone International, Inc.
(MEDS)
Atrix Laboratories, Inc. (ATRX) Neoprobe Corporation (NEOP)
Biomatrix, Inc. (BIOX)
BioSource International, Inc. (BIOI) Organogenesis, Inc. (ORG)
Boston Biomedica Inc. (BBII) Pace Health Management Systems, Inc. (PCES)
Cambridge NeuroScience, Inc. (CNSI) Patient Infosystems, Inc. (PATI)
CollaGenex Pharmaceuticals, Inc. (CGPI) PerSeptive Biosystems, Inc.
(PBIO)
CompDent Corporation (CPDN) PharmaPrint Inc. (PPRT)
Conceptus, Inc. (CPTS) Physician Support Systems,
Cypros Pharmaceutical Corporation (CYPR) Inc. (PHSS)
Diametrics Medical, Inc. (DMED) Physiometrix, Inc. (PHYX)
Draxis Health Inc. (DRAXF) PLC Systems, Inc. (PLC)
DUSA Pharmaceuticals, Inc. (DUSA) PolyMedica Industries, Inc. (PM)
Eclipse Surgical Technologies, Inc.
(ESTI) QuadraMed Corporation (QMDC)
ENDOcare, Inc. (ENDO) Quality Systems, Inc. (QSII)
Endovascular Technologies, Inc. (EVTI) Quantech Ltd. (QQQQ)
Erox Corporation (EROX) Rockford Industries, Inc. (ROCF)
Exactech, Inc. (EXAC) RoTech Medical Corporation
(ROTC)
First Commonwealth, Inc. (FCWI) Sabratek Corporation (SBTK)
GranCare, Inc. (GC) Safeguard Health Enterprises,
Inc. (SFGD)
Hanger Orthopedic Group, Inc. (HGR) Sheridan HealthCare, Inc. (SHCR)
Hemagen Diagnostics, Inc. (HMGN) Techniclone Corporation
(TCLN)
Hooper Holmes, Inc. (HH) Texas Biotechnology Corporation
(TXB)
HumaScan Inc. (HMSC) Thoratec Laboratories
Corporation (THOR)
ID Biomedical Corporation (IDBEF) Trimedyne, Inc. (TMED)
Image Guided Technology, Inc. (IGTI) Ultrafem, Inc. (UFEM)
Unimed Pharmaceuticals, Inc. (UMED) Imatron Inc. (IMAT)
United Dental Care, Inc. (UDCI)
The Immune Response Corporation (IMNR) UROHEALTH Systems, Inc. (UROH)
IMNET Systems, Inc. (IMNT) Utah Medical Products, Inc. (UM)
InnerDyne, Inc. (IDYN) Voxel (VOXL)
Interpore International (BONZ) Xenometrix, Inc. (XENO)
KV Pharmaceutical Company (KV.A/KV.B) Zonagen, Inc. (ZONA)
Laserscope (LSCP)
Private Companies
BioStar, Inc. Norian Corporation
Energy Life Systems Corporation OraPharma, Inc.
IntraVascular Medical, Inc. PrISMedical Corporation
Laurus Medical Corporation RayMedica, Inc.
NeoVision Corporation
SOURCE Cruttenden Roth |
